Ukuba wena okanye othandekayo unayo i- MS eqhubekayo , unokuziva uxhalabile okanye udidekile ukuba akukho miyeza evunyiweyo yolu hlobo lwesifo. Kodwa qiniseka ukuba, abaphandi basebenza nzima, kwaye uphando luya kuvela.
Olunye unyango olunjalo luyilo oluphezulu lokuvelisa i-vitamin biotin. Masiqwalasele ngokuphandle uphando lwezenzululwazi emva kwe-biotin ekuphatheni i-sclerosis.
Inkqubela ye-MS ne-Relapsing-Remitting MS
Nangona uninzi lwabantu abane-multiple sclerosis luye lwabuyisela i-MS (malunga nama-85 ekhulwini), i-subset encinci (malunga ne-10 ukuya kwe-15 ekhulwini) ine- MS ephambili . Oku kuthetha ukuba ababuyiselwa ukubuyiselwa kobudala bokungasebenzi kwegazi.
I-biology emva kokuphindaphinda kwe-MS kukuba isistim somzimba somntu sihlasela i-myelin sheath. Ngamanye amazwi, ukuphindaphinda kwakhona inkqubo yokuqhuma. Kodwa kwi-MS eqhubela phambili, inkqubo encinci yokuvuvukala kunye neyokuguqulwa komninzi iyenzeka, apho i-nerve fibers iya kuhlahloka. Ngoko umntu onenkqubela ye-MS eqhubekayo ekwenzeni ukonakalisa intsholongwane yengqondo ngaphandle kwexesha lokuxolelwa.
I-SEC yesiqhelo sesibini eqhubekayo ichaza umntu oye waphinda wafumana ukuhlaziya, kodwa ngoku uguqule kwinkqubo encinci ye-MS. Uninzi lwabantu abane-MS-reing-MS ekugqibeleni luya kutshintshwa kwi-MS eqhubekayo.
Nangona, oku kungashintsha kunye nokusetyenziswa kwezifo zokuqala zokuguqula izifo.
I-Biotin njengeNyango yoLwazi
Ukususela ekubeni isifo-sokuguqulwa kwezifo (ezijolise kumanyathelo omzimba omzimba) azisebenzi kakuhle ekuphatheni i-MS eqhubekayo (ngaphandle kokuba umntu efumana ukubuyela kwakhona), abaphandi baye bazama ukufumana unyango olunokujolisa kwipateni yokuqhubekayo ye-sclerosis.
Ngamanye amagama, isicatshulwa esijolise kwinkqubo yesantya esiyintloko kunye nesistim somzimba.
Kubaphandi, i-vitamin biotin ibonakala ngathi yinto efanelekileyo, ngokuqwalasela ukuba sele ifunyenwe ukuphatha ngokuthe ngxaki ezinye iinkqubo ezinzima kakhulu zesistim kwiingxaki eziphezulu. Ukuthetha ngezesayensi, njani i-biotin yayiza kunceda umntu oqhubela phambili kwi-MS? I-Biotin idlala indima ekwenzeni i-acid acids emzimbeni, kwaye i-myelin sheath yinqumle. Ngoko, izazinzulu ziqikelela ukuba i-biotin inokuqalisa ukuhlanganiswa kwama-acids acids, oku kunokukhokelela ekulungiseni i-myelin kunye nokukhusela umonakalo we-nerve kunye nokulahleka.
Uphando lweBeot Biotin
Uphononongo lokuqala oluhlolisise ukuphathwa kwe-MS eqhubekayo kunye ne-biotin kwakufundwa ngesiFrentshi kwi- Multiple Sclerosis kunye neengxaki ezichaphazelekayo . Kule sifundo, abantu abangama-23 abaneenkqubela phambili (abantu abayi-14) okanye i-MS ehamba phambili (abantu abayisithoba) banikezwa ukunyuka kwamaxabiso e-biotin imihla ngemihla (i-100mg ukuya ku-600mg) kwisilinganiso esiphakathi kweenyanga ezilisithoba.
Iziphumo zolu phando zityhile oku kulandelayo:
- Abantu abane babenomdla ongapheliyo kwi-MS-related optic nerve disease ngaphambi kokufunda. Bonke babenokuphuculwa kwezinto ezibonakalayo kunye ne-biotin ephezulu (300mg / imini).
- Omnye umntu wayenomntu ongekho phantsi kwe-hemianopia ngaphambi kokufundwa (oku kuthetha ukuba icala langasekhohlo linye lalingaboni kakuhle). Lo mntu wayephuculwe ngumbono, nangona i-lesion yokudibanisa kwengqondo yakhe i-MRI yayingatshintshi.
- Abantu abayi-18 babenomdla wokugcoba umgudu ngaphambi kokuba bafunde-abantu abane-11 ababenesifo esinyameko se-tetraparesis (ukukhubazeka okwexeshana okanye okugqibeleleyo kweengalo ezine) kunye nabantu abasixhenxe abane-paraparesis (ukukhubazeka okuqhelekileyo okanye okugqibeleleyo kwezitho zomzimba ezimbini). Abantu abalishumi elinesibhozo kwezi-18 (iipesenti ezingama-89) zaphucula (ezenzeka kwiinyanga ezimbini ukuya kwezibhozo emva kokuba unyango lwe-biotin luqale).
Kulabo baphuculweyo (okwakuchazwa ngumhloli oyimfama ophonononga ii-videotapes zeemviwo zeklinikhi), uphuculo olulungileyo lubonwe ngamanani aphezulu e-biotin, kwi-300mg / ngosuku.
Ezinye iimpawu ezinxulumene ne-MS kunye neempawu eziphuculweyo zibandakanya:
- ukukhathala (abantu abahlanu)
- ukugwinya iingxaki (abantu abane)
- ukuthetha okucothayo okanye ukuthetha ngentetho (abathathu abantu)
- iimpawu zengqondo (abantu ababini)
- ukuhamba ngokungahambelani-okubizwa ngokuba yi-gait ataxia (abantu ababini)
Ekugqibeleni, ukukhubazeka, njengoko kulinganiswe ngamanqaku e- EDSS , kuphuculwe kwabafundi abane (23 ekhulwini).
Impembelelo embi kuphela echazwe kwiphononongo yayisifo sohudo esingaphantsi kweyabini kubantu. Umntu oyedwa wafa ngenxa yokuhluleka kwentliziyo iminyaka emithathu emva kokuqala unyango lwe-biotin kwaye unyaka owodwa emva kokuba unyango luqalwe, umntu wafa ngenxa yempumoniya emva kokuba aphethwe yi-colon. Zombini iziganeko zokufa zazingakholelwa ukuba zihambelana nokunyanga nge-biotin.
Kwakhona, khumbula ukuba abantu abaneenkqubela phambili ze-MS banokuhlaziya ngokuphindaphindiweyo. Esi sifundo, abantu abane (13 ekhulwini) bafumana ubuncinane bodwa i-MS kwakhona. Kodwa ngokutsho kwabaphandi, le nombolo yayifana noko kwakuboniswa kula bantu phambi kokunyanga nge-biotin. Ngamanye amazwi, i-biotin ayibonakali kakubi okanye inempembelelo yentsholongwane ye-MS kwakhona.
Enye i-Biotin Study for Treatment MS
Kwesinye isiFundo seFrench kwi- Multiple Sclerosis , abantu abane-MS eyimpumelelo okanye yesibini abahamba phambili babenomsebenzi wokufumana i-100mg biotin okanye indawo ye-placebo (iipilisi zajonga kwaye zanambitha ngokufanayo) kathathu imihla ngemihla (ngoko zizonke ezingama-300mg biotin imihla ngemihla, ukuba kungekhona indawo ye-placebo ).
Abathathi-nxaxheba abafundayo okanye abaphandi abaphandiweyo babesazi ukuba ngubani owamkela ipilisi ye-biotin kwaye owathola ipilisi ye-placebo. Oku kwenziwa konyaka omnye (obizwa ngokuba yinqanaba lokuqala). Ekugqibeleni, abantu abayi-91 bafumana ipilisi ye-biotin kunye nabantu abangama-42 bafumana ipilisi ye placebo.
Emva koko omnye unyaka, bonke abathathi-nxaxheba (kubandakanye abathathi-nxaxheba be-placebo) bafumana i-100mg biotin kathathu imihla ngemihla (ebizwa ngokuthi isigaba sokwandisa). Bengazange bazi ukuba ngaba bafumene i-biotin unyaka wokuqala okanye indawo ye-placebo.
Iziphumo zityhila ukuba i-13 (i-12,6 ekhulwini) yabathathi-nxaxheba baphathwa nge-biotin kwasekuqaleni bekuncipha ekukhubazekeni kwabo okumalunga ne-MS, kwaye aba-10 kulaba bathathi-13 bathathe intuthuko ekupheleni kokufunda (iinyanga ezingama-24). Abantu ababini abafumana i-biotin kwisigaba sokuqala abazange babonise ukuphucula kwiinyanga ezili-12 zokuqala kodwa benza ekupheleni kweenyanga ezingama-24.
Ukuphuculwa kokukhubazeka kuye kwalinganiswa ngokunciphisa amanqaku e-EDSS kunye / okanye ukunciphisa ixesha elifunekayo ukuhamba ngeenyawo ezingama-25. Umkhabi apha apha ukuba akukho phuculo kwiqela le-placebo, ebonisa ukuba i-biotin ibe nefuthe lokwenene. Kwakhona, kufana nesifundo sokuqala esicacisiwe, i-biotin yayinyamezeleke, ngaphandle kwemiphumo emibi.
Oku kuthetha konke, malunga nombandela okhankanywe ngababhali bokufunda kukuba abo bafumene i-biotin babenokwanda olutsha okanye ukwandisa izilonda zobuchopho (njengoko kuboniswe kwi-MRI) kunezo zeqela le-placebo. Ngoko umbuzo uvela nokuba i-biotin ibangela ukuphinda uvuseleleke ngokusebenza komzimba womzimba? Yingakho uphando oluthe lufunekayo.
ILizwi
Ezi zifundo zibonisa ntoni? Bacetyisa ukuba i-biotin inokwenza ngokukhuselekileyo nangokunceda ukuguqula ukuqhubela phambili kokukhubazeka kubantu abane-MS ephambili okanye yesibili. Nangona kunjalo, uphando olunzulu nolunzulu lufuneka luyenziwe ngaphambi kokuba ziphi na izigqibo. Ngokomzekelo, kuya kuba luncedo ukubheka izilonda zobuchopho kwi-MRIs kwizifundo ezizayo.
Kwakhona, uphando olusakhulayo lubonisa ukuba i-biotin ayinakusebenza kakuhle ekuphatheni ubuqhetseba obubonakalayo, obangela iingcali ukuba zikhange iintloko zazo. Ngokubanzi, kufuneka zigqitywe iimfuno ezikhulu ukuze zihlaziye inzuzo yangempela ye-biotin kwi-multiple sclerosis. Le yinkqubo eyinkathazo, kwaye ngelixa lidla ixesha, liyiyo inomdla okanye umthandayo.
> Imithombo:
> I-MS Society Society. Imibuzo ebuzwa rhoqo nge-SPMS.
> Sedel F et al. Amanani aphakamileyo ye-biotin kwi-eplexosis yokuqhubekayo eninzi yokuqhubekayo: isifundo somqhubi. Ukungqubuzana kweMult Scler Relation . Ngo-2015 uMar; 4 (2): 159-69.
> Tourbah A et al. MD1003 (i-high-dose biotin) ukunyanga kwe-multiple sclerosis: I-study-controlled controlled-blind-blind, i-placebo. Mult Scler. 2016 Nov; 22 (13): 1719-31.